Soc. Generale Call 72.5 NDAQ 20.0.../ DE000SW74DQ6 /
2024-06-06 10:02:53 AM | Chg.+0.001 | Bid1:41:18 PM | Ask1:41:18 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.024EUR | +4.35% | 0.023 Bid Size: 35,000 |
0.033 Ask Size: 35,000 |
Nasdaq Inc | 72.50 USD | 2024-09-20 | Call |
GlobeNewswire
1:57 PM
Ocuphire Pharma Announces Presentations on the Development of APX3330 for Diabetic Retinopathy at Re...
GlobeNewswire
1:40 PM
OneMedNet Significantly Expands Industry Access to Proprietary iRWD™ Network and Platform by Joining...
GlobeNewswire
1:30 PM
Research Frontiers and AIT Group Unveil Revolutionary Retrofittable SPD-SmartGlass Window At AIA Con...
GlobeNewswire
1:30 PM
4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Mo...
GlobeNewswire
1:30 PM
Breckenridge Distillery Wins Double Gold for a Consecutive Year in a Row at the 2024 New York Intern...
GlobeNewswire
1:30 PM
Shattuck Labs to Host Investor Call and Webcast on Additional Interim Data Presented at the European...
GlobeNewswire
1:30 PM
BridgeBio Pharma to Participate in the 45th Annual Goldman Sachs Global Healthcare Conference
GlobeNewswire
1:29 PM
Orion’s Q4’24 Revenue Rose 22% to $26.4M; FY’24 Revenue of $90.6M Driven by Growth Across LED Lighti...
GlobeNewswire
1:00 PM
IAE AG and FTAI Aviation Sign Strategic V2500® Engine Maintenance Services Agreement
GlobeNewswire
1:00 PM
Chemomab Therapeutics Presents Data Supporting the Clinical Potential of CM-101 as a Novel Treatment...
GlobeNewswire
1:00 PM
Relay Therapeutics Discloses Three New Programs at New Program & Platform Event
GlobeNewswire
1:00 PM
Replimune Announces Positive Topline Primary Analysis Data by Independent Central Review from IGNYTE...
GlobeNewswire
1:00 PM
Aclaris Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
12:45 PM
U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri’s...
GlobeNewswire
12:30 PM
Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Sc...